This research work proposes the evaluation of the implementation of a tele-orientation program and tele-consultation to the adult population with RA attended at a specialized rheumatology center in Bogota, Colombia, over a period of three months, by means of a observational, analytical, cohort, prospective study that will include mixed methods for collecting information (quantitative and qualitative)
The evaluation of the priority implementation of a non-face-to-face multidisciplinary health care model is justified in a population highly vulnerable to COVID 19, with Rheumatoid arthritis (RA) in a health emergency situation and in turn seeking to promote its well-being, taking into account the importance of interdisciplinary follow-up to strengthen self-care, avoid deterioration, hospital admissions and improve therapeutic adherence. This research work proposes the evaluation of the implementation of a tele-orientation program and tele-consultation to the adult population with RA attended at a specialized rheumatology center in Bogota, Colombia, over a period of three months, by means of a observational, analytical, cohort, prospective study that will include mixed methods for collecting information (quantitative and qualitative). The qualitative methods will include interviews with a subgroup of patients attending by the two models and with the professionals who care for them, with the aim of knowing the experiences and perceptions of both the patients and the professionals. The impact that the project seeks is focused on evaluating the program's contribution to the control of RA symptoms and inflammation, avoiding progressive structural damage. On the other hand, elements will be provided to advance towards telehealth educational interventions and their effect in improving the therapeutic adherence of patients with RA, as well as avoiding their displacement, maintaining quarantine measures and stimulating necessary self-care measures in search of mitigate the COVID-19 pandemic and counteract the spread of the severe acute respiratory syndrome coronavirus 2, particularly in this susceptible risk group. Finally, this study will provide information on the characteristics of RA patients who choose telemedicine compared to face-to-face care when both are offered as usual care options during an unprecedented situation such as the COVID-19 pandemic. For this reason, the possibility of replication at the national level from the planning of telemedicine programs in rheumatology will be essential for contributing to the reduction of epidemiological indicators against contagion by coronavirus and the use of hospital service
Study Type
OBSERVATIONAL
Enrollment
200
A group of patients who have voluntarily adhered to the clinic's tele-assisted consultation and who receive remote, multidisciplinary team care without requiring physical displacement.
Group of patients who wish to continue with the usual face-to-face consultation, since for these patient's isolation measures allow trips to the care centers and who receive care from a multidisciplinary team on a regular basis.
BIOMAP IPS Centro de Atención Integral en Artritis Reumatoide
Bogota, Cundinamarca, Colombia
RECRUITINGColombia Fundación Universitaria de Ciencias de la Salud-FUCS
Bogota, Cundinamarca, Colombia
RECRUITINGEvaluation of the implementation of a non-face-to-face multidisciplinary consultation model in a population of rheumatoid arthritis
Evaluate the implementation of a non-face-to-face multidisciplinary consultation model in a population with rheumatoid arthritis, highly vulnerable to severe acute respiratory syndrome coronavirus 2 \[coronavirus disease (COVID-19)\] during a health emergency situation and evaluation of the effectiveness of their results.
Time frame: up to Week 12
Epidemiological characterization
Epidemiological characterization of the population evaluated under the multidisciplinary health care model, both in teleconsultation and face-to-face consultation.
Time frame: up to Week 12
Proportion of individuals infected
To determine the proportion of individuals infected with severe acute respiratory syndrome coronavirus 2 \[coronavirus disease (COVID-19)\] in those patients who regularly receive different immunosuppressive medications under the two care models (teleconsultation and face-to-face).
Time frame: up to Week 12
Risk factors for infection
Describe the risk factors for severe acute respiratory syndrome coronavirus 2 \[coronavirus disease (COVID-19)\] infection in the group of patients linked to the teleconsultation model and in those with regular face-to-face care.
Time frame: up to Week 12
Risk factors for hospitalization
Describe the risk factors for hospitalization associated with severe acute respiratory syndrome coronavirus 2 \[coronavirus disease (COVID-19)\] in the group of patients linked to the teleconsultation model and in those with regular face-to-face care.
Time frame: up to Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Risk factors for mortality
Describe the risk factors for mortality associated with severe acute respiratory syndrome coronavirus 2 \[coronavirus disease (COVID-19)\] in the group of patients linked to the teleconsultation model and in those with regular face-to-face care.
Time frame: up to Week 12
Average change from baseline in Disease Activity Score with 28-joint counts [DAS28] in face-to-face consultation group
A single score on a continuous scale (0-9.4). The level of disease activity will be interpreted as remission (DAS28 \<2.6), low (2.6 ≤ DAS28 \< 3.2), moderate (3.2 ≤DAS28≤ 5.1), or high (DAS28 \>5.1).
Time frame: up to Week 12
Average change from baseline in Patient Activity Scale scores in both groups tele-assisted consultation and face-to-face consultation
The Patient Activity Scale is calculated by multiplying the Health Assessment Questionnaire (HAQ) by 3.33 and then dividing the sum of the visual analogue scale (VAS) pain, Patient global assessment (PtGA), and Health Assessment Questionnaire (HAQ) by 3. Activity will be interpreted as these categories of disease activity: remission ≤0.25, low ≤3.7, moderate \<8.0, and high ≥8.0.
Time frame: up to Week 12
Evaluation of participant's pain using visual analogue scale [VAS] in both groups tele-assisted consultation and face-to-face consultation
Paint measurement for any disease state 0-10 centimeters VAS by the patient
Time frame: Baseline, Week 6 and 12
Evaluation of the disease activity by Doctor using visual analogue scale [VAS] in both groups tele-assisted consultation and face-to-face consultation
Activity measurement for any disease state 0-10 centimeters VAS by the Doctor
Time frame: Baseline, Week 6 and 12
Absolute and percent change in the Health Assessment Questionnaire (HAQ) in both groups tele-assisted consultation and face-to-face consultation
The questionary includes 20 daily life questions, grouped in 8 areas, each one containing two or three questions related to daily life activities. Each question is scored from 0-3. 0 means no disability, 3 score means completely disabled. The average of all responses is done. Average scores from 0-1 represent "mild to moderate difficulty", 1-2 means "moderate to severe disability", 3-2 indicates "severe to very severe disability".
Time frame: Baseline, Week 6 and 12
Average change from baseline in European Quality of Life 5 Dimensions (EQ-5D) questionnaire in both groups tele-assisted consultation and face-to-face consultation
European Quality of Life 5 Dimensions (EQ-5D) questionnaire is a self-reported health outcome which measures Quality of life (QoL) in five dimensions. An overall score is derived that measures from the least (worst) to the highest score (best). In addition, health state is measured on the vertical Visual Analogue scale (score 0 to 100) with higher scores (better health status).
Time frame: up to Week 12
Evaluation of the level of therapeutic adherence using a specific Scale in both groups tele-assisted consultation and face-to-face consultation
The four item MORISKY-GREEN-LEVINE Medication Adherence Scale (MGLS) results in a score ranging from 0 to 4. There are three levels of medication adherence based on this score: high, medium and low adherence with 0, 1-2, and 3-4 points, respectively. A dichotomous definition of adherence based on MGLS will be used with 0 points indicating perfect adherence and 1+ points indicating some level of non-adherence.
Time frame: Baseline and week 12.
Evaluation of the self-care capacity using the Appraisal of Self-care Agency Scale -Revised (ASA-R) in both groups tele-assisted consultation and face-to-face consultation
The Appraisal of Self-care Agency Scale -Revised (ASA-R; Sousa et al.) is one of the main instruments to assess self-care capacity. It consists of a total of 15 questions in 3 areas, of which the area lacking self-care agency is reversely coded. Based on a 5-point Likert scale, a higher total score signified a higher level of self-care agency.
Time frame: Baseline and week 12.